Yasutake Tada

Real-world long-term continuation of lecanemab therapy and the clinical utility of phosphorylated tau 181

This real-world study evaluated the long-term feasibility of lecanemab treatment in 117 patients with early Alzheimer's disease at Kanazawa University Hospital. To assess treatment persistence over a full 18-month course, we focused on the 64 patients who initiated treatment betw...